Sarna en niños del área oriente de Santiago / Scabies in children of orient area of Santiago

Se estudió a 123 niños, en los que se sospechó la exsitencia de sarna, frente a los siguientes hallazgos clínicos: prurito de inicio insidioso o no, erupción cutánea, y las características epidemiológicas típicas. Se consideró recientes a los casos que presentaron un tiempo de evolución inferior a 30 días (57 niños), y a los restantes (65 pacientes), de evolución prolongada. Las edades oscilaron entre 1 y los 120 meses. En 113 niños (91,9 por ciento ), la erupción cutánea fue el hallazgo más fercuente. Prurito se manifestó en 99 pacientes, en tanto que infección de otros contactos en 92 casos (74 por ciento ). En 71 (57,7 por ciento ) niños, sólo se presentó sarna exclusivamente, en 24 (19,5 por ciento ) se asoció a infección bacteriana, en 18 (14,6 por ciento ) a hipersensibilidad y sarna, infección bacteriana e hipersensibilidad en 10 (8,2 por ciento ). Los gérmenes que más frecuentemente se aislaron fueron de S. aureus en 11 casos, y la asociación de S. pyogenes en lo de ellos. El Acaro test tuvo un rendimiento global de un 20,3 por ciento (25 niños), presentando su mayor utilidad en los casos de larga evolución, en que no se aplicó acaricidas previamente (33,3 por ciento ). De los antisárnicos utilizados, el lindano al 1 por ciento tuvo un rendimiento de 75 por ciento (48 niños), el crotamitón al 10 por ciento en loción, de 94,9 por ciento (47 pacientes) y la vaselina azufrada al 5 por ciento de 77,8 por ciento (7 casos). Se destaca la eficiencia del crotamitón en loción en esta patología

Efficacy of an in-feed preparation of ivermectin against endoparasites and scabies mites in swine.

In 2 trials, the efficacy of an in-feed preparation of ivermectin was evaluated in 40 pigs naturally infected with endoparasites and Sarcoptes scabiei var suis. Treated pigs (n = 10 in each trial) were fed a ration containing 2 ppm ivermectin for 7 days, followed by consumption of a nonmedicated ration for the remainder of the trial. Control pigs (n = 10 in each trial) were fed a complete, nonmedicated ration for the duration of the trial. Pigs in trial A were monitored for 14 days after treatment; those in trial B were monitored for 35 days after treatment. In trial A, treatment efficacy of ivermectin was 100% against Ascaris suum, Physocephalus sexalatus, Oesophagostomum dentatum, O brevicaudum, Metastrongylus spp; 99.8% against Ascarops strongylina; 90.9% against Trichuris suis; and 13.1% against Macracanthorhynchus hirudinaceus. At the terminus of the trial, statistically significant (P less than 0.05) differences were observed between numbers of treated and control pigs infected with A suum, Ascarops strongylina, and Oesophagostomum spp. On posttreatment day 14, S scabiei were not found in any scrapings taken from treated pigs, but were found in scrapings from 3 of 10 control pigs. The number of infested pigs in the treatment group was not statistically different from the number of infested pigs in the control group. In trial B, treatment efficacy was 100% for A suum and Metastrongylus spp; 96.9% for Ascarops strongylina; and 76.9% for M hirudinaceus. At the terminus of the trial, statistically significant (P less than 0.05) differences were evident between numbers of treated and control pigs infected with A suum, Ascarops strongylina, and Metastrongylus spp.(ABSTRACT TRUNCATED AT 250 WORDS)

Efficacy of topically applied ivermectin against sarcoptic mange (Sarcoptes scabiei var. bovis) of cattle.

A total of 12 adult cattle with sarcoptic mange were included in a study to confirm the efficacy of ivermectin applied topically at 500 micrograms/kg against Sarcoptes scabiei var. bovis. Animals were allocated by restrictive randomization according to mite counts to serve as untreated controls or were treated with a topical formulation of ivermectin applied along the backline on healthy skin. Mites were counted in epidermal scrapings made prior to treatment and at 7, 14, 21, 28, 42 and 56 days thereafter. Except for three mites recovered from one animal on day 28, no mites were found after day 14 over the remainder of the trial in scrapings from animals treated with ivermectin. Differences in the numbers of mites recovered from animals treated with ivermectin and those found on controls were significant (P less than 0.05) for counts carried out on days 14-56. Clinical signs of mange resolved following treatment, whereas the extent of lesions and severity of clinical signs increased in the control animals over the trial period.

Genital ulcer disease in women in Durban, South Africa.

OBJECTIVE: To study the microbial aetiology of genital ulcer disease (GUD) in women. DESIGN: Microbial and clinical assessment of genital ulcers in women. SETTING: City Health sexually transmitted diseases clinic, King Edward VIII Hospital, Durban, South Africa. PARTICIPANTS: 100 Zulu women with genital ulceration who had not received antibiotics in the previous two weeks. RESULTS: Syphilis was diagnosed in 40%, genital herpes in 18%, donovanosis (granuloma inguinale) in 16%, chancroid in 14%, lymphogranuloma venereum in 7% and scabies in 2%. No recognised cause was detected in 18%. Secondary syphilis was diagnosed in 21%, primary syphilis in 16% and mixed primary and secondary syphilis in 3%. Multiple infections were detected in 13 women, of whom 12 had syphilis. Bleeding was observed from the ulcers of 59 during swab collection. Three women had HIV-1 antibodies. Neisseria gonorrhoeae was isolated from the ulcers and endocervix of two women and from the endocervix alone in nine. Generalised scabies was diagnosed in 14. CONCLUSIONS: All the major causes of GUD are prevalent in Zulu women in Durban: secondary syphilis was the commonest diagnosis. Donovanosis, which often presents late with large ulcers, and genital herpes are now significant problems. Mixed infections with coexisting syphilis are common. All women in this population with GUD should be treated for syphilis and receive oral antibiotics effective for chancroid and donovanosis.

Genital ulcer disease in men in Durban, South Africa.

OBJECTIVE: To study the microbial aetiology of genital ulcer disease (GUD) in men. DESIGN: Microbiological and clinical assessment of genital ulcers in men. SETTING: City Health sexually transmitted diseases clinic, King Edward VIII Hospital, Durban, South Africa. PARTICIPANTS: 100 Zulu men with genital ulcers who had not received antibiotics in the previous four weeks. RESULTS: Syphilis was diagnosed in 42%, chancroid in 22%, donovanosis (granuloma inguinale) in 11%, genital herpes in 10% and lymphogranuloma venereum (LGV) in 6%. No pathogens were identified in 24%. Mixed infections were detected in 14 men, in whom 13 had syphilis. Five men had HIV-1 antibodies. Neisseria gonorrhoeae was isolated from the ulcers and urethra in seven men and from the urethra alone in five. Scabies was diagnosed clinically in eight. CONCLUSIONS: All the major causes of GUD are prevalent in Zulu men in Durban. Primary syphilis was the commonest and was invariably present in mixed infections. Donovanosis was under-reported and was associated with a long delay before presentation. In this population, genital ulcers other than superficial lesions should be treated with anti-syphilitic therapy and oral antibiotics effective against chancroid and donovanosis.

Treatment and control of sarcoptic mange: evaluation of treatment of both the pigs and environment.

Pigs in a herd infected with Sarcoptes scabiei var suis were treated with 20% phosmet at a dose rate of 20 mg/kg body weight. In one of the groups the environment was also treated using 2% trichlorphon. Post-treatment clinical examination and parasitological evaluation of skin scrapings revealed complete recovery by the end of the second month after initial treatment with no evidence of reinfection for a period of five months.

Sarcoptes scabiei in histopathologic sections of skin in human scabies.

The usual methods of diagnosis remove Sarcoptes scabiei from its habitat. Thus, one has no appreciation of the host-endoparasitic interaction, especially the pathologic response of the surrounding tissue and the means by which the mite survives and lives its life cycle in the skin. The biopsy specimen described in this article demonstrates the tissue reaction that can be correlated with clinical symptoms. It also clearly depicts the actual position, morphological features, and developmental cycle of the mite in the skin.

Epidemiological studies of sarcoptic mange in Tanzanian pig herds.

An epidemiological survey of sarcoptic mange in 32 herds with a total herd size of 2,021 pigs was conducted in three representative climatic zones in Tanzania. The disease was present in all zones in varying prevalences. The overall prevalences were 52% and 21% when determined on the basis of clinical examination and mite isolation respectively and 91% of the herds were shown to be harbouring the disease.

Density, location, and sampling of Sarcoptes scabiei (Acari: Sarcoptidae) on experimentally infested pigs.

Forty-eight weaned pigs were inoculated with 0 (controls), 100 (low dose), and 1,000 (high dose) itch mites, Sarcoptes scabiei (De Geer), and allowed to develop infestations for up to 10 wk. Pigs were slaughtered in sequence during the experiment to sample hides and count mites through potassium hydroxide digestion. Incipient crusted lesions occurred in ears of 4 of 16 low-dose pigs and 7 of 16 high-dose pigs, averaged less than 3 cm2 in area, and contained 86% of all females and 87% of all other mite stages found on those pigs. Crusts aside, faces had the highest mite densities among six body regions in both infested groups. Overall, high-dose pigs had higher mite populations (269 compared with 39 mites on low-dose pigs), although values were not significantly different (P = 0.13). Mite populations did not grow significantly during the 10 wk, but variance increased among pigs in each dose group. A hide-sampling plan derived from these data indicates whole-body populations could be estimated by censusing only the crusts, if present. If absent, sampling mites from the face and dorsum should provide acceptable estimates of whole-body totals of females and other stages. A sample size of 13 hides from a herd will yield an estimate of mean whole-body total with a 90% CI less than or equal to 50% of the estimated mean.

Neonatal scabies.

A case of scabies infestation in a ten-week-old infant is described. Infestation in a neonate presents a clinical picture quite different from that found in older children and adults. Therapeutic options can be limited in infants. Current concepts and treatment modalities are discussed.

Prevalence of Sarcoptes scabiei in the homes and nursing homes of scabietic patients.

This study determined the prevalence of Sarcoptes scabiei in the home environment of 37 confirmed cases of scabies and in five nursing homes with scabietic patients. Dust samples from 44% of infested patients' homes contained scabies mites. Live mites at the time the dust samples were analyzed were present in 64% of these homes. Live mites were recovered most often from bedroom floors or overstuffed chairs and couches. The density of live and dead mites ranged from 1 to 5 mites/0.1 gm of dust or 1 to 9 mites/m2 of surface area sampled. The presence of mites in fomites coupled with survival and host-seeking behavior indicate that it is possible for a person to become infested by dislodged mites in contaminated home, school, and work environments. By contrast, only a small number of mites were recovered from beds, furniture, and floors of scabies-infested nursing homes. Mite-contaminated fomites may be less important in the transmission of scabies in nursing homes than in private homes.

[Clinical effects of ivermectin in the treatment of Sarcoptes scabiei var canis in farm foxes]. / Klinisk effekt av ivermectin ved behandling av Sarcoptes scabiei var canis på farmrev.

The efficacy of ivermectin against natural infection of the mange mite Sarcoptes scabiei var canis in foxes was evaluated. The investigations consisted of two field studies and one controlled study. In experiment 1, ivermectin was given as a single subcutaneous dose at 200 micrograms/kg in six foxes. In experiment 2, was one group, consisting of five animals, administered 200 micrograms ivermectin/kg s.c. twice with an interval of 35 days. Group two, consisting of four animals, was given one subcutaneous injection of 400 micrograms ivermectin/kg. In experiment 3, ten foxes were given 1 ml 0.2% Eqvalen s.c. (i.e. 340-440 micrograms ivermectin/kg). A control group of ten animals was not medicated. Before and after treatment a clinical evaluation and skin scraping for microscopic examination was carried out in all three experiments. The results indicated that ivermectin was a good alternative in the therapy of the Sarcoptes mange in foxes by moderate mite infection. A progressive clinical improvement of the mange lesions was evident in the treated foxes. Mites were not detected in skinscraping, except in one animal in experiment 3. It was concluded that ivermectin should be administered, in an initial dose of 400 micrograms/kg and a repeated dose of 200 micrograms/kg 2-3 weeks after the first treatment.